SCHEMBL740115

SCHEMBL740115

CCC(S)CCCCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.52
FFAR1 O14842 2/20 0.52
ALDH1A1 P00352 3/20 0.50
GSTK1 Q9Y2Q3 2/20 0.50
AKR1B1 P15121 1/20 0.50
ENPEP Q07075 1/20 0.48
KMT2A Q03164 2/20 0.48
MAPT P10636 1/20 0.48
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 6/20 0.48
PPARD Q03181 6/20 0.48
PPARA Q07869 6/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 4/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
PTPN1 P18031 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10769646 0.93 ENPEP (0.47) FFAR4FFAR1ALDH1A1GSTK1AKR1B1
SCHEMBL15956044 0.84 TSHR (0.60) FFAR4FFAR1ALDH1A1GSTK1ENPEP
SCHEMBL867829 0.84
SCHEMBL12506523 0.83 FFAR4 (0.69) FFAR4FFAR1ALDH1A1AKR1B1KMT2A
SCHEMBL21772258 0.83 FFAR4 (0.69) FFAR4FFAR1ALDH1A1AKR1B1KMT2A
SCHEMBL2349520 0.83 FFAR4 (0.69) FFAR4FFAR1ALDH1A1AKR1B1KMT2A
SCHEMBL31046957 0.83 ALDH1A1 (0.61) FFAR4FFAR1ALDH1A1GSTK1AKR1B1
SCHEMBL12384963 0.83 FFAR4 (0.69) FFAR4FFAR1ALDH1A1AKR1B1KMT2A
SCHEMBL1516585 0.83 ALDH1A1 (0.61) FFAR4FFAR1ALDH1A1GSTK1AKR1B1
SCHEMBL10942819 0.83 FFAR4 (0.69) FFAR4FFAR1ALDH1A1AKR1B1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0599199-B1 Silver halide photographic emulsions sensitized in the presence of organic disulfides and sulfinates EASTMAN KODAK CO (US) 1997-03-12 EP claimed
US-5364754-A Silver halide photographic emulsions precipitated in the presence of organic dichalcogenides EASTMAN KODAK COMPANY (US) 1994-11-15 US claimed
US-5328820-A Precipitation of silver halide, sensitization and adding antifogging agents EASTMAN KODAK COMPANY (US) 1994-07-12 US claimed
EP-0599199-A1 Silver halide photographic emulsions sensitized in the presence of organic disulfides and sulfinates EASTMAN KODAK COMPANY (US) 1994-06-01 EP claimed
EP-0566074-A2 Silver halide photographic emulsions precipitated in the presence of organic dichalcogenides EASTMAN KODAK COMPANY (US) 1993-10-20 EP claimed
US-20180305231-A1 COMPOSITE, A METHOD OF MAKING THEREOF, AND A METHOD FOR DEGRADING A POLLUTANT KING ABDULAZIZ UNIVERSITY (SA) 2018-10-25 US disclosed
US-9284541-B2 Methods and compositions for protein labeling using lipoic acid ligases MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-03-15 US disclosed
US-8871456-B2 Probe incorporation mediated by enzymes MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-10-28 US disclosed
WO-2013052851-A1 METHODS AND COMPOSITIONS FOR POLYPEPTIDE AND PROTEIN LABELING USING LIPOIC ACID LIGASES SPECIFIC TO RESORUFIN MASSACHUSETTS INISTITUTE OF TECHNOLOGY (US) 2013-04-11 WO disclosed
US-20120214201-A1 PROBE INCORPORATION MEDIATED BY ENZYMES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-08-23 US disclosed
US-20120129159-A1 METHODS AND COMPOSITIONS FOR PROTEIN LABELING USING LIPOIC ACID LIGASES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-05-24 US disclosed
US-8137925-B2 Methods and compositions for protein labeling using lipoic acid ligases MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-03-20 US disclosed
EP-0599199-B1 Silver halide photographic emulsions sensitized in the presence of organic disulfides and sulfinates EASTMAN KODAK CO (US) 1997-03-12 EP disclosed
US-5364754-A Silver halide photographic emulsions precipitated in the presence of organic dichalcogenides EASTMAN KODAK COMPANY (US) 1994-11-15 US disclosed
EP-0617320-A2 Tabular grain emulsions containing antifoggants and stabilizers EASTMAN KODAK COMPANY (US) 1994-09-28 EP disclosed
US-5328820-A Precipitation of silver halide, sensitization and adding antifogging agents EASTMAN KODAK COMPANY (US) 1994-07-12 US disclosed
US-5320938-A Occurs in the presence of iodide EASTMAN KODAK COMPANY (US) 1994-06-14 US disclosed
EP-0599199-A1 Silver halide photographic emulsions sensitized in the presence of organic disulfides and sulfinates EASTMAN KODAK COMPANY (US) 1994-06-01 EP disclosed
EP-0566074-A2 Silver halide photographic emulsions precipitated in the presence of organic dichalcogenides EASTMAN KODAK COMPANY (US) 1993-10-20 EP disclosed
US-4087282-A COPOLYMERS OF ISOBUTYLENE AND MALEIC ACID DERIVATIVES FUJI PHOTO FILM CO., LTD. (JA) 1978-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129159-A1 METHODS AND COMPOSITIONS FOR PROTEIN LABELING USING LIPOIC ACID LIGASES LARS1, ACSL5, RARS1 FFAR4 3562/4885FFAR1 2922/4885ALDH1A1 1936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.